Gene Predictis is a Swiss company dedicated to precision medicine. We develop innovative diagnostic tools based on genetics that allow tailored treatments for patients. Our products enable to improve drug treatment efficacy and/or significantly reduce harmful side effects resulting from adverse drug reactions. We also develop genetic tests that help to establish predictive diagnosis, paving the way to a highly personalised medical advice.
Currently the company focuses on developing tools to personalise drug treatments and contribute to prevention of certain diseases such as thromboembolism related to birth control pills.
In parallel, Gene Predictis proposes its services of medical testing laboratory for genetic and molecular microbiology analyses.
Our central laboratory is authorized by the Swiss medical authorities (the Federal Office for Public Health, fr. OFSP, de. BAG) for both genetic and molecular microbiology medical testing services. The panels of the services we offer are all based on DNA/RNA technologies and are listed under “Products & Services”.
The company is based at EPFL Innovation Park (École Polytechnique Fédérale de Lausanne) in Lausanne, Switzerland, and aims to become the reference company in precision medicine, notably concerning personalized drug prescription.
OUR ENGAGEMENT TOWARDS PATIENTS AND MEDICAL COMUNITY
Gene Predictis engages to perform all medical analyses to the highest quality standards and conforms to the relevant ISO 15189:2012 and ISO 17025:2005 quality norms. We also engage to respect medical secrecy and confidentiality of the patient information.
We support our commitment through:
Our highly experienced team of specialists
Our highly professional staff
Regular monitoring, audits and quality controls
Adherence to the relevant national and international standards
1015 Lausanne, Svizzera